Takeda Pharmaceutical is a global pharmaceutical company with a presence in more than 70 regions and territories around the world, committed to striving for patients' better health worldwide. The company has a dynamic 231-year history and is currently the top pharmaceutical company in Japan and Asia, as well as one of the top 20 pharmaceutical firms globally. Takeda pursues its mission through intensive innovation in R&D and in-licensing opportunities in four strategic areas: metabolic and CV, oncology, CNS diseases, and immunology and inflammation. In pursuit of its vision of sustainable growth and greater contribution to all stakeholders, Takeda is passionate in its commitment to its three strategic pillars Innovation, Culture and Growth in order to adapt to the world's rapidly changing landscape. With the addition of Nycomed to the Takeda family in 2011, the company is dedicated to increasingly providing leading medicines to ever more patients around the world.